Olympus Optical to market Xillix' LIFE-Lung:
This article was originally published in Clinica
Xillix plans to appoint Olympus Optical as worldwide distributor for the Canadian company's LIFE-Lung cancer detection system. The agreement builds on the collaborative research, development and marketing deal signed by the two companies in August 1994, which covers gastrointestinal cancer detection (see Clinica No 616, p 20).
You may also be interested in...
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.